Mineralys Therapeutics 2026 annual meeting results: directors elected, auditor ratified

Mineralys Therapeutics, Inc.

Elected three Class III directors to serve until 2029: Akkaraju (67.1M for), Slingsby (67.1M for), Karydas (66.6M for).
Ratified Ernst & Young as independent auditor for fiscal year 2026 with 72.6M votes for, 9.5K against.
Broker non-votes of 5.6M shares on director election proposals; no non-votes on auditor ratification.
All proposals passed with requisite affirmative votes as described in the April 8, 2026 proxy statement.

item 5.07

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001933414-26-000090
form_type: 8-K
ticker: MLYS
cik: 0001933414
company_name: Mineralys Therapeutics, Inc.
filed_at: 2026-05-22T20:50:14+00:00
discovered_at: 2026-05-22T20:51:00.336398+00:00
generated_at: 2026-05-22T20:52:23.219999+00:00
sec_items: ["5.07"]
event_type: other
sentiment: neutral
materiality_score: 0.1
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001933414-26-000090
json_url: https://secwatch.observer/filing/0001933414-26-000090.json
markdown_url: https://secwatch.observer/filing/0001933414-26-000090.md
text_url: https://secwatch.observer/filing/0001933414-26-000090.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1933414/000193341426000090/0001933414-26-000090-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1933414/000193341426000090/mlys-20260521.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001933414-26-000090

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.